Introduction
Hepatoma-specific AFP and AFP-messenger RNA
HS-GGT isoforms
AFP (ng/mL) | No. | HS-GGT (>5.5 IU/L) | |
---|---|---|---|
Positive (%) | Negative (%) | ||
<50 | 49 | 39 (79.6) | 10 (20.4) |
51~499 | 28 | 27 (96.4) | 1 (3.6) |
500~999 | 18 | 16 (88.9) | 2 (11.1) |
>1,000 | 61 | 53 (86.9) | 8 (13.1) |
Total | 156 | 135 (86.5) | 21 (13.5) |
Glypican-3 and its gene transcription
Group | No. of cases | GPC-3 | χ2
|
P
| |
---|---|---|---|---|---|
Positive | Negative | ||||
Sex | |||||
Male | 103 | 74 | 29 | 0.379 | 0.538 |
Female | 20 | 13 | 7 | ||
Age | |||||
≥60 years | 56 | 39 | 17 | 0.059 | 0.808 |
<60 years | 67 | 48 | 19 | ||
TNM staging | |||||
I and II | 47 | 39 | 8 | 5.551 | 0.019 |
III and IV | 76 | 48 | 28 | ||
Tumor size | |||||
≥3.0 cm | 98 | 65 | 33 | 4.520 | 0.034 |
<3.0 cm | 25 | 22 | 3 | ||
AFP (ng/mL) | |||||
≥400 | 52 | 36 | 16 | 0.098 | 0.754 |
<400 | 71 | 51 | 20 | ||
HBsAg | |||||
Positive | 89 | 79 | 10 | 50.571 | <0.001 |
Negative | 34 | 8 | 26 | ||
Tumor number | |||||
Single | 58 | 40 | 18 | 0.165 | 0.685 |
Multiple | 65 | 47 | 18 | ||
Child-Pugh | |||||
A | 60 | 40 | 20 | 1.005 | 0.605 |
B | 45 | 34 | 11 | ||
C | 18 | 13 | 5 | ||
Periportal cancer embolus | |||||
With | 44 | 44 | 0 | 28.347 | <0.001 |
Without | 79 | 43 | 36 | ||
Extrahepatic metastasis | |||||
With | 65 | 65 | 0 | 57.019 | <0.001 |
Without | 58 | 22 | 36 |
GPC-3 | GPC-3 mRNA | AFPa
| Total | |
---|---|---|---|---|
Sensitivity (%) | 52.8 | 70.7 | 70.7 | 94.3 |
Specificity (%) | 98.8 | 99.8 | 86.2 | 85.8 |
Diagnostic accuracy (%) | 83.5 | 89.4 | 81.0 | 88.6 |
Positive predictive value (%) | 95.6 | 96.7 | 71.9 | 76.8 |
Negative predictive value (%) | 80.7 | 87.1 | 85.5 | 96.8 |